Literature DB >> 28796382

Physician- and self-assessed myasthenia gravis activities of daily living score.

Hye Lim Lee1, Ju-Hong Min2,3, Jin Myoung Seok4, Eun Bin Cho5, Hye Jin Cho6, Yong-Dae Kim7, Byoung Joon Kim2,3.   

Abstract

INTRODUCTION: The Myasthenia Gravis-Activities of Daily Living (MG-ADL) profile scale is a simple-to-use instrument. We aimed to validate this scale in the Korean language and compare physician- and self-assessed MG-ADL scores (pMG-ADL-K and sMG-ADL-K).
METHODS: pMG-ADL-K and sMG-ADL-K and MG Composite (MGC) scores were obtained from patients. The correlation between pMG-ADL-K and MGC and the relationship between the pMG-ADL-K and sMG-ADL-K were assessed using the Cronbach α and the Spearman coefficient. By intraclass correlation coefficient (ICC), the reliability of each sub-item of pMG-ADL-K and sMG-ADL-K was evaluated.
RESULTS: We included data from 40 patients. The pMG-ADL-K score showed a strong correlation with the MGC score (rho = 0.80, P < 0.01). The Cronbach α was 0.98 between pMG-ADL-K and sMG-ADL-K, and sub-items showed good consistency (ICC 0.684-0.985, P < 0.001). DISCUSSION: The MG-ADL-K is a valid tool and the sMG-ADL-K shows excellent correlation with pMG-ADL-K. Both the pMG-ADL-K and sMG-ADL-K can be used to measure MG severity. Muscle Nerve 57: 419-422, 2018.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  MG Composite scale; MG clinical trial; MG-ADL; Myasthenia Gravis-Activities of Daily Living profile; myasthenia gravis; myasthenia gravis scales

Mesh:

Year:  2017        PMID: 28796382     DOI: 10.1002/mus.25764

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  The Impact of the Coronavirus Disease-2019 Pandemic on the Psychological Status and Quality of Life of Myasthenia Gravis Patients.

Authors:  Aleksandar Stojanov; Jelena Stojanov; Vuk Milosevic; Marina Malobabic; Goran Stanojevic; Milos Stevic; Gordana Djordjevic
Journal:  Ann Indian Acad Neurol       Date:  2020-05-08       Impact factor: 1.383

2.  Factors associated with quality of life of people with Myasthenia Gravis.

Authors:  Ansuk Jeong; Ju-Hong Min; Yu Kyoung Kang; Juhyeon Kim; Misong Choi; Jin Myoung Seok; Byung Joon Kim
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

Review 3.  Utilization of MG-ADL in myasthenia gravis clinical research and care.

Authors:  Srikanth Muppidi; Nicholas J Silvestri; Robin Tan; Kimberly Riggs; Trevor Leighton; Glenn A Phillips
Journal:  Muscle Nerve       Date:  2022-01-06       Impact factor: 3.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.